Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Mol Cancer Res. 2019 Oct 14;17(12):2480–2491. doi: 10.1158/1541-7786.MCR-19-0654

Figure 2.

Figure 2.

Assessment of C-circle levels of LAPC-4 ATRXKO and CWR22Rv1 ATRXKO clones. (A) Blot of C-circle assay generated from U2OS, an ALT-positive cell line. C-circles are absent in PC3 (ALT-negative prostate cancer cell line). (B) C-circle assays were performed with a U2OS (positive control) standard curve to determine relative C-circle levels in LAPC-4 (C&E) and CWR22Rv1 (D&F).